ACRE MEDICAL LIMITED

Dissolved United Kingdom

Wholesale of pharmaceutical goods

3 employees website.com
Healthcare and wellbeing Wholesale of pharmaceutical goods
A

ACRE MEDICAL LIMITED

Wholesale of pharmaceutical goods

Founded 22 Feb 2018 Dissolved United Kingdom 3 employees website.com
Healthcare and wellbeing Wholesale of pharmaceutical goods
Accounts Submitted 2 Dec 2025 Next due 31 Jan 2027 8 months remaining
Confirmation Submitted 26 Nov 2025 Next due 10 Dec 2026 6 months remaining
Net assets £41K £6K 2025 year on year
Total assets £41K £235K 2025 year on year
Total Liabilities £0 £230K 2025 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Telephone

0800 000 0000

Website

www.example.com

Full company profile for ACRE MEDICAL LIMITED (11219024), a dissolved healthcare and wellbeing company based in United Kingdom. Incorporated 22 Feb 2018. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2025
Type total-exemption-full
Next accounts 30 Apr 2026
Due by 31 Jan 2027 8 months remaining

Net Assets, Total Assets & Total Liabilities (2018–2025)

Cash in Bank

£6.00

Net Assets

£40.57k

Decreased by £5.51k (-12%)

Total Liabilities

N/A

Decreased by £229.98k (-100%)

Turnover

N/A

Employees

3

Debt Ratio

N/A

Decreased by 83 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Apr Year End
2024
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Pritchard, IanDirectorBritishEngland565 Aug 2019Active

Shareholders

Shareholders (2)

C.s.t. Pharma Group Holdings Limited
50.0%
Robert Melville & Melville Holdings Limited
50.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Robert Arthur Melville

British

Active
Notified 22 Feb 2018
Residence England
DOB January 1969
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Dean Spotswood

Ceased 5 Oct 2023

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Apr 2026GazetteGazette Dissolved Voluntary
20 Jan 2026GazetteGazette Notice Voluntary
12 Jan 2026DissolutionDissolution Application Strike Off Company
2 Dec 2025AccountsAnnual accounts made up to 30 Apr 2025
26 Nov 2025Confirmation StatementConfirmation statement made on 26 Nov 2025 with no updates
7 Apr 2026 Gazette

Gazette Dissolved Voluntary

20 Jan 2026 Gazette

Gazette Notice Voluntary

12 Jan 2026 Dissolution

Dissolution Application Strike Off Company

2 Dec 2025 Accounts

Annual accounts made up to 30 Apr 2025

26 Nov 2025 Confirmation Statement

Confirmation statement made on 26 Nov 2025 with no updates

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 months ago on 7 Apr 2026

Gazette Notice Voluntary

4 months ago on 20 Jan 2026

Dissolution Application Strike Off Company

4 months ago on 12 Jan 2026

Annual accounts made up to 30 Apr 2025

5 months ago on 2 Dec 2025

Confirmation statement made on 26 Nov 2025 with no updates

6 months ago on 26 Nov 2025